ClassID:

20900

A61K38/08 - page 7 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Peptides having 5 to 11 amino acids

Recent Application in this class:
#1801
20160215019
2016-07-28

Peptides capable of reactivating p53 mutants

#1802
20160213793
2016-07-28

Somatostatin analogs with inhibitory activity to growth hormone release

#1803
20160213738
2016-07-28

Cardiovascular disease treatment and prevention

#1804
20160213737
2016-07-28

Methods and Compositions for Treating Conditions

#1805
20160206750
2016-07-21

Block copolymers

#1806
20160206741
2016-07-21

Hydrogels for delivery of therapeutic compounds

#1807
20160206736
2016-07-21

Ligands to radiation-induced molecules

#1808
20160206692
2016-07-21

Engineered integrin binding peptide compositions

#1809
20160206680
2016-07-21

ANTI-TRYPANOSOME COMPOUNDS AND TREATMENTS

#1810
20160206679
2016-07-21

Methods for increasing DISC1 in a subject with schizophrenia or bipolar disorder by an antagonist inhibiting DISC1 binding to FBXW7

#1811
20160200763
2016-07-14

Glycogen synthase kinase-3 inhibitors

#1812
20160193301
2016-07-07

Eye drop formulation

#1813
20160193279
2016-07-07

Methods and compositions for the treatment of axonal and neuronal degeneration

#1814
20160184603
2016-06-30

Method and system for treating wounds

#1815
20160184447
2016-06-30

Car peptide for homing, diagnosis and targeted therapy for pulmonary and fibrotic disorders

#1816
20160184444
2016-06-30

Microparticles containing physiologically active peptide, method for preparing the same, and pharmaceutical composition comprising the same

#1817
20160184385
2016-06-30

Peptide having ability to synthesize collagen and use thereof

#1818
20160177298
2016-06-23

Channel modulators

#1819
20160176924
2016-06-23

Modified peptides as potent inhibitors of the PSD-95/NMDA receptor interaction

#1820
20160176923
2016-06-23

NONAPEPTIDE WITH ANTI-TUMOUR ACTIVITY

#1821
20160175405
2016-06-23

Fusion proteins and methods for treating HIV infection and AIDS related symptoms

#1822
20160175399
2016-06-23

IL-13 receptor binding peptides

#1823
20160175383
2016-06-23

CALCIMIMETICS AND METHODS FOR THEIR USE

#1824
20160175382
2016-06-23

Compositions and methods for inducing urinary voiding and defecation

#1825
20160175381
2016-06-23

Intraarticular application of pepstatin in the case of arthrosis

#1826
20160175259
2016-06-23

Targeted Nanocarrier Systems for Delivery of Actives Across Biological Membranes

#1827
20160175246
2016-06-23

Pharmaceutical formulations of desmopressin

#1828
20160166654
2016-06-16

COLLAGEN-TARGETED NANOPARTICLES

#1829
20160159863
2016-06-09

Antibody targeting through a modular recognition domain

#1830
20160158375
2016-06-09

DIPEPTIDE LINKED MEDICINAL AGENTS

#1831
20160158372
2016-06-09

Cardiovascular disease treatment and prevention

#1832
20160158296
2016-06-09

Lactococcus lactis strains for producing bioactive peptides having anti-hypertensive and cholesterol-lowering effects

#1833
20160158270
2016-06-09

Biomaterials comprising hyaluronic acid binding peptides and extracellular matrix binding peptides for hyaluronic acid retention and tissue engineering applications

#1834
20160152665
2016-06-02

Compositions and methods of treatment of cancers

#1835
20160151511
2016-06-02

PROTEINS AND PROTEIN CONJUGATES WITH INCREASED HYDROPHOBICITY

#1836
20160151510
2016-06-02

Use of hydrophobic organic acids to increase hydrophobicity of proteins and protein conjugates

#1837
20160151470
2016-06-02

Method of inducing a T lymphocyte response using T-cell immunogens derived from anti-viral proteins

#1838
20160151456
2016-06-02

LIPOPEPTIDE INHIBITORS OF RAS ONCOPROTEINS

#1839
20160151449
2016-06-02

USE OF TIGHT JUNCTION ANTAGONISTS TO TREAT INFLAMMATORY BOWEL DISEASE

#1840
20160151448
2016-06-02

MULTIMERIC TIE 2 AGONISTS AND USES THEREOF IN STIMULATING ANGIOGENESIS

#1841
20160151447
2016-06-02

Pharmaceutical composition for a sustained release of lanreotide

#1842
20160151446
2016-06-02

Peptide therapeutics and methods for using same

#1843
20160145309
2016-05-26

Disulfide cyclic polypeptides for the treatment of heart failure

#1844
20160145308
2016-05-26

Compositions and methods for targeted endometriosis treatment

#1845
20160145301
2016-05-26

Process for the manufacture of degarelix and its intermediates

#1846
20160145297
2016-05-26

Hydroxy-ethylene derivatives for the treatment of arthrosis

#1847
20160143986
2016-05-26

Methods and systems for delivery of ZW1 heptapeptide

#1848
20160136229
2016-05-19

MATERIALS FOR POSITIVE CATHEPSIN B MODULATION AND METHODS OF USE FOR TREATING MILD COGNITIVE IMPAIRMENT (MCI), EARLY DEMENTIA, A-SYNUCLEINOPATHY, TRAUMATIC BRAIN INJURY, CARDIOMYOPATHY, EYE DISEASE AND SKIN DAMAGE

#1849
20160130579
2016-05-12

Adipocyte-targeting non-viral gene delivery system

#1850
20160129095
2016-05-12

Immunostimulatory combinations

#1851
20160129071
2016-05-12

Nutritional supplements containing a peptide component and uses thereof

#1852
20160122415
2016-05-05

Methods and compositions for the treatment of cancer

#1853
20160120966
2016-05-05

Biological markers useful in cancer immunotherapy

#1854
20160120933
2016-05-05

Inhibitors of mitochondrial fission and methods of use thereof

#1855
20160120932
2016-05-05

TRANSPLANT SITE-FORMING AGENT, TRANSPLANT SITE-FORMING DEVICE, ANGIOGENIC AGENT AND ANGIOGENIC DEVICE

#1856
20160120846
2016-05-05

Arthroscopic Irrigation Solution and Method for Peripheral Vasoconstriction and Inhibition of Pain and Inflammation

#1857
20160114053
2016-04-28

Methods and compositions for delivering active agents with enhanced pharmacological properties

#1858
20160106860
2016-04-21

CONJUGATES OF A GLYCOPROTEIN OR A GLYCAN WITH A TOXIC PAYLOAD

#1859
20160106847
2016-04-21

Low-burst polymers and methods to produce polymer

#1860
20160106803
2016-04-21

USE OF TIGHT JUNCTION ANTAGONISTS IN THE TREATMENT OF ACUTE LUNG INJURY AND ACUTE RESPIRATORY DISTRESS

#1861
20160106802
2016-04-21

METHODS OF DIAGNOSING AND TREATING ASTHMA

#1862
20160106801
2016-04-21

Wound healing agent

#1863
20160101151
2016-04-14

Compounds and methods of modulating angiogenesis

#1864
20160101150
2016-04-14

Peptides having anti-inflammatory properties

#1865
20160089415
2016-03-31

Elastin protective polyphenolics and methods of using the same

#1866
20160089414
2016-03-31

Inhibitors of NOX1

#1867
20160083733
2016-03-24

NOVEL TREATMENT OF METABOLIC DISEASES

#1868
20160083429
2016-03-24

COMPOSITIONS AND METHODS FOR ENDOTOXIN NEUTRALIZATION

#1869
20160082115
2016-03-24

Reverse thermal gels and uses therefor

#1870
20160082103
2016-03-24

Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds

#1871
20160081932
2016-03-24

NEUTRALLY-CHARGED SYNTHETIC PLATELETS TO MITIGATE COMPLEMENT RESPONSE

#1872
20160081903
2016-03-24

Method for promoting hair growth

#1873
20160075740
2016-03-17

Antifungal agents and uses thereof

#1874
20160075738
2016-03-17

Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions

#1875
20160074508
2016-03-17

Compositions for stimulation of mammalian innate immune resistance to pathogens

#1876
20160074468
2016-03-17

Combination anti-human epidermal growth factor receptor 2 (anti-HER2) cancer therapy using mucin 1 (MUC1) peptides and hemotherapeutics

#1877
20160074463
2016-03-17

Use of the PAT nonapeptide in the treatment and prevention of neurodegenerative diseases

#1878
20160074461
2016-03-17

LLP2A-bisphosphonate conjugates for osteoporosis treatment

#1879
20160068568
2016-03-10

Modulators of the SRC-kinase activity for preventing or treating metastatic cancer

#1880
20160068567
2016-03-10

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

#1881
20160068566
2016-03-10

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

#1882
20160067347
2016-03-10

APJ RECEPTOR AGONISTS AND USES THEREOF

#1883
20160058873
2016-03-03

Cyclodextrin-Based Polymers for Therapeutic Delivery

#1884
20160058871
2016-03-03

Self-assembling peptide and polysaccharide complexes

#1885
20160058828
2016-03-03

Methods, uses and compositions of Tie2 agonists

#1886
20160058827
2016-03-03

Combination anti-estrogen receptor cancer therapy using MUC1 peptides and chemotherapeutics

#1887
20160051623
2016-02-25

Anti-angiogenic peptides and uses thereof

#1888
20160046674
2016-02-18

Enopeptins, uses thereof, and methods of synthesis thereto

#1889
20160041189
2016-02-11

Biomarker for detecting white matter stroke, containing toll-like receptor 2, and medical use of toll-like receptor 2

#1890
20160041181
2016-02-11

NMR ASSAY TO SCREEN PROTEIN-PROTEIN INTERACTION INHIBITORS

#1891
20160039873
2016-02-11

Peptides with antifungal activity and methods of using the peptides

#1892
20160038460
2016-02-11

Compositions and methods for drug-sensitization or inhibition of a cancer cell

#1893
20160033529
2016-02-04

Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same

#1894
20160033478
2016-02-04

Use of GPR83 to identify pruritus-related substances

#1895
20160032394
2016-02-04

Method for reversing recent-onset type 1 diabetes (T1D) by administering substance P (sP)

#1896
20160032368
2016-02-04

Methylation detection of the MGMT promoter

#1897
20160031947
2016-02-04

Cupredoxin derived transport agents and methods of use thereof

#1898
20160031941
2016-02-04

TARGETING PEPTIDES THAT BIND S. MUTANS, CONSTRUCTS COMPRISING SUCH PEPTIDES AND USES THEREOF

#1899
20160030631
2016-02-04

Injectable Biodegradable Bone Matrix for Multiple Myeloma Lesion Augmentation and Osteoporosis

#1900
20160030585
2016-02-04

Fatty acids and their use in conjugation to biomolecules

#1901
20160030509
2016-02-04

Methods for attenuating release of inflammatory mediators and peptides useful therein

#1902
20160030504
2016-02-04

METHOD FOR REVERSING RECENT-ONSET TYPE 1 DIABETES (T1D) BY ADMINISTERING SUBSTANCE P (sP)

#1903
20160030503
2016-02-04

SELECTIVE NOX-1 INHIBITOR PEPTIDES AND USES THEREOF

#1904
20160030454
2016-02-04

Cancer therapy

#1905
20160022831
2016-01-28

Peptides that Selectively Home to Heart Vasculature and Related Conjugates and Methods

#1906
20160022764
2016-01-28

Pharmaceutical compositions

#1907
20160022762
2016-01-28

Agent for Eliminating Multidrug Resistance

#1908
20160022761
2016-01-28

DEREPRESSION OF IMMUNITY IN ONCOLOGICAL AND VIROLOGICAL CONDITIONS BY HIGH MOBILITY GROUP BOX 1 DERIVED PEPTIDES

#1909
20160022760
2016-01-28

METHODS OF TREATING CELIAC DISEASE WITH LARAZOTIDE

#1910
20160022759
2016-01-28

Methods for increasing the selective efficacy of gene therapy using CAR peptide and heparan-sulfate mediated macropinocytosis

#1911
20160017292
2016-01-21

Selective targeting of cancer stem cells

#1912
20160017040
2016-01-21

Anti-B7-H4 antibodies and immunoconjugates

#1913
20160017011
2016-01-21

PHF20 AND JMJD3 COMPOSITIONS AND METHODS OF USE IN CANCER IMMUNOTHERAPY

#1914
20160015833
2016-01-21

Heteromultivalent particle compositions

#1915
20160015773
2016-01-21

Inhibiting peptides derived from TREM-like transcript 1 (TLT-1) and uses thereof

#1916
20160015772
2016-01-21

High purity oritavancin and method of producing same

#1917
20160015771
2016-01-21

METHOD OF TREATING OPTIC NERVE DAMAGE, OPHTHALMIC ISCHEMIA OR OPHTHALMIC REPERFUSION INJURY

#1918
20160011195
2016-01-14

Method of Forming Fragment Ligated Inhibitors

#1919
20160008485
2016-01-14

Engineered antibody constant regions for site-specific conjugation and methods and uses therefor

#1920
20160008481
2016-01-14

Self-assembling complex for targeting chemical agents to cells

#1921
20160008291
2016-01-14

Peptide-based hydrogel particles and uses thereof

#1922
20160008274
2016-01-14

TREATMENT OF NAIL DISORDERS

#1923
20160002725
2016-01-07

Use of TRPC6 mRNA levels in peripheral blood cells for early detection/diagnosis of senile dementia

#1924
20160002303
2016-01-07

Functional peptides for obesity disorders

#1925
20160002293
2016-01-07

Methods for the treatment of mitochondrial diseases associated with a mutation in or gene resulting in a disruption of mitochondrial oxidative phosphorylation

#1926
20160000880
2016-01-07

Methods for treating multiple sclerosis

#1927
20160000860
2016-01-07

Enhancement of bone morphogenic protein (BMP) retention with BMP binding peptide (BBP)

#1928
20160000858
2016-01-07

COMPOSITIONS AND METHODS FOR MITIGATING SKIN IRRITATION AND ENHANCING SKIN BARRIER FUNCTION

#1929
20150368300
2015-12-24

Compositions and methods relating to hindering DOT1L recruitment by MLL-fusion proteins

#1930
20150368297
2015-12-24

Peptide compound for inhibiting restenosis and promoting re-endothelialization and method for preparing the same

#1931
20150366990
2015-12-24

Antibody-linker-drug conjugate, preparation method therefor, and anticancer drug composition containing same

#1932
20150366987
2015-12-24

Monoclonal antibodies against HER2 epitope and methods of use thereof

#1933
20150366982
2015-12-24

Protein-polymer-drug conjugates and methods of using same

#1934
20150361161
2015-12-17

Anti-ED-A immunoconjugates for inflammatory bowel disease

#1935
20150361147
2015-12-17

Cancer antigen EEF2

#1936
20150361138
2015-12-17

KISS1R receptor agonist compounds and use thereof for inducing ovulation in mammals

#1937
20150359843
2015-12-17

p53 activating peptides

#1938
20150359840
2015-12-17

Autophagy-inducing peptide analogs

#1939
20150359746
2015-12-17

Technology for the Preparation of Microparticles

#1940
20150353930
2015-12-10

Methods of treating a metabolic syndrome by modulating heat shock protein (HSP) 90-beta

#1941
20150353676
2015-12-10

Polymeric nanoparticles and a process of preparation thereof

#1942
20150353603
2015-12-10

Endometriosis cell targeting peptide and uses thereof

#1943
20150352220
2015-12-10

Self-assembling ultrashort peptides modified with bioactive agents by click chemistry

#1944
20150352148
2015-12-10

METHODS FOR PREVENTING OR TREATING INFECTIOUS DISEASES CAUSED BY EXTRACELLULAR MICROORGANISMS, INCLUDING ANTIMICROBIAL-RESISTANT STRAINS THEREOF, USING GALLIUM COMPOUNDS

#1945
20150344522
2015-12-03

Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs thereof

#1946
20150343014
2015-12-03

TOPICAL ANTIMICROBIAL DERMATOLOGICAL COMPOSITION

#1947
20150342852
2015-12-03

Compounds useful in the treatment and/or care of the skin, hair and/or mucous membranes and their cosmetic or pharmaceutical compositions

#1948
20150335753
2015-11-26

Supersaturated stabilized nanoparticles for poorly soluble drugs

#1949
20150335701
2015-11-26

Recovery and processing of human embryos formed in vivo

#1950
20150335700
2015-11-26

Recovery and processing of human embryos formed in vivo

#1951
20150335354
2015-11-26

Recovery and processing of human embryos formed in vivo

#1952
20150329912
2015-11-19

BIOMARKERS IN CANCER, METHODS, AND SYSTEMS RELATED THERETO

#1953
20150329591
2015-11-19

Azapeptides as CD36 binding compounds

#1954
20150328296
2015-11-19

Nasal vaccine against the development of atherosclerosis disease and fatty liver

#1955
20150328283
2015-11-19

NOVEL ANTIMICROBIAL AGENTS

#1956
20150320826
2015-11-12

TREATMENT OF INFLAMMATION AND/OR ENDOTOXIC SHOCK

#1957
20150320825
2015-11-12

Saposin-A derived peptides and uses thereof

#1958
20150315555
2015-11-05

Fragment ligated inhibitors selective for the polo box domain of PLK1

#1959
20150314007
2015-11-05

LINKER-PAYLOAD MOLECULE CONJUGATES

#1960
20150313957
2015-11-05

Chemical induction of lactation in male non-human mammals

#1961
20150307552
2015-10-29

NOVEL D-ENANTIOMERIC PEPTIDES DERIVED FROM D3 AND USE THEREOF

#1962
20150307550
2015-10-29

Peptide pharmaceuticals

#1963
20150306240
2015-10-29

Hydroxyl-polymer-drug-protein conjugates

#1964
20150306236
2015-10-29

BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF

#1965
20150306235
2015-10-29

Sugar chain-attached linker, compound containing sugar chain-attached linker and physiologically active substance or salt thereof, and method for producing same

#1966
20150306213
2015-10-29

HMGB1-derived peptides enhance immune response to antigens

#1967
20150306168
2015-10-29

Methods of protecting against apoptosis using lipopeptides

#1968
20150299279
2015-10-22

Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

#1969
20150299264
2015-10-22

Inhibition of cardiac fibrosis in myocardial infarction

#1970
20150297735
2015-10-22

Conjugates for treating diseases caused by PSMA expressing cells

#1971
20150297671
2015-10-22

Peptide analogues with branched amino acid probe(s)

#1972
20150297670
2015-10-22

Therapeutic use of peptide inhibitors of NADPH oxidase; aerosolization as a delivery mechanism

#1973
20150297669
2015-10-22

Pharmaceutical composition for treating medical conditions and a method for treating alimentary disorders and related diseases

#1974
20150297668
2015-10-22

Analogs of C5a and methods of using same

#1975
20150292032
2015-10-15

TREATMENT OF CANCER BY TARGETING QUIESCENT CANCER CELLS

#1976
20150290339
2015-10-15

NOVEL COMPOUND WITH EFFECTS OF THROMBOLYSIS, FREE RADICAL SCAVENGING AND THROMBUS-TARGETING AS WELL AS PREPARATION METHOD AND USE THEREOF

#1977
20150284434
2015-10-08

Peptides as oxytocin agonists

#1978
20150284433
2015-10-08

Peptides that stimulate subcutaneous adipogenesis

#1979
20150284430
2015-10-08

Application of SP peptide or derivative thereof in preparing medicines for preventing or treating asthma

#1980
20150284427
2015-10-08

Macrocyclic compounds for inhibition of inhibitors of apoptosis

#1981
20150283201
2015-10-08

IMPLANTABLE DEVICE FOR THE DELIVERY OF OCTREOTIDE AND METHODS OF USE THEREOF

#1982
20150274782
2015-10-01

Gamma-AApeptides with potent and broad-spectrum antimicrobial activity

#1983
20150273020
2015-10-01

Hormone Normalization Therapy and Uses Therefor

#1984
20150273012
2015-10-01

Use of degarelix in the treatment of endometriosis and related diseases

#1985
20150273011
2015-10-01

TOPICAL CORNEAL ANALGESIA USING NEUROTENSIN RECEPTOR AGONISTS AND SYNERGISTIC NEUROTENSIN COMBINATIONS WITHOUT DELAYING WOUND HEALING

#1986
20150273010
2015-10-01

HIGH-THROUGHPUT ASSAYS FOR HIV-1 ENVELOPE MATURATION AND NOVEL PEPTIDE INHIBITORS AGAINST HIV-1

#1987
20150272982
2015-10-01

Product for use in the prophylactic or therapeutic treatment of a negative emotion or introvert behaviour

#1988
20150265535
2015-09-24

SUSTAINED-RELEASE LIPID PRE-CONCENTRATE OF CATIONIC PHARMACOLOGICALLY ACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

#1989
20150265533
2015-09-24

Nanoemulsion for transdermal delivery and method of making the same

#1990
20150265530
2015-09-24

Biodegradable microdepot delivery system for topical delivery

#1991
20150259385
2015-09-17

Pharmaceutical composition for cancer prevention and treatment containing peptide originated from C12orf59 protein as an active ingredient

#1992
20150259384
2015-09-17

Method for preventing neoplastic transformation by inhibition of retinoblastoma protein inactivation

#1993
20150259380
2015-09-17

Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides

#1994
20150258192
2015-09-17

COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING CHRONIC LUNG ALLOGRAFT DYSFUNCTION (CLAD) AND IDIOPATHIC PULMONARY FIBROSIS (IPF)

#1995
20150258165
2015-09-17

Methods for the treatment of X-linked hypophosphatemia and related disorders

#1996
20150252087
2015-09-10

Treatment of brain injury with a neurotrophic peptide

#1997
20150250850
2015-09-10

Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome

#1998
20150250848
2015-09-10

Therapy and kit for the prevention and treatment of cystic fibrosis

#1999
20150250847
2015-09-10

Peptides for suppressing inflammation

#2000
20150250699
2015-09-10

TRPV3 AGONISTS FOR THE TREATMENT OF SKIN CONDITIONS

#2001
20150246955
2015-09-03

Methods and compositions for specific modulation of MCL-1

#2002
20150246946
2015-09-03

PEPTIDES AND METHODS FOR TREATING CANCER

#2003
20150246120
2015-09-03

MOESIN MODULATORS AND USES THEREOF

#2004
20150239935
2015-08-27

Hydrogen bond surrogate macrocycles as modulators of Ras

#2005
20150238559
2015-08-27

Methods of treating rheumatoid arthritis

#2006
20150238558
2015-08-27

IAP antagonists

#2007
20150238557
2015-08-27

Method of treatment or prophylaxis of infections of the eye

#2008
20150231205
2015-08-20

COMPOSITIONS AND METHODS FOR THE TREATMENT OF MYOCARDIAL ISCHEMIA/REPERFUSION INJURY WITH ANNEXIN A1 SHORT PEPTIDE

#2009
20150231195
2015-08-20

COMPETITIVE INHIBITORS OF INVARIANT CHAIN EXPRESSION AND/OR ECTOPIC CLIP BINDING

#2010
20150225458
2015-08-13

Synthetic artificial peptides with antimicrobial effect

#2011
20150224166
2015-08-13

Sincalide Formulations

#2012
20150224165
2015-08-13

Compositions and methods for treating ischemia

#2013
20150218277
2015-08-06

Inhibitors of the Epidermal Growth Factor Receptor- Heat Shock Protein 90 Binding Interaction

#2014
20150218213
2015-08-06

INHIBITORS OF ALPHA6 INTEGRIN/E-CADHERIN COMPLEX

#2015
20150216990
2015-08-06

Polypeptide and lipophilic moiety conjugate compositions, formulations, and uses related thereto

#2016
20150216980
2015-08-06

Stabilizing alkylglycoside compositions and methods thereof

#2017
20150216939
2015-08-06

Methods of treating mild brain injury

#2018
20150216819
2015-08-06

Agents useful for treating obesity, diabetes and related disorders

#2019
20150216806
2015-08-06

LAXATIVE COMPOSITIONS AND METHODS FOR TREATING CONSTIPATION AND RELATED GASTROINTESTINAL DISEASES AND CONDITIONS

#2020
20150202322
2015-07-23

Intestinal peptide targeting ligands

#2021
20150202251
2015-07-23

MULTIMERIC TIE 2 AGONISTS AND USES THEREOF IN STIMULATING ANGIOGENESIS

#2022
20150202249
2015-07-23

Anti-androgen peptides and uses thereof in cancer therapy

#2023
20150202248
2015-07-23

E2F as a target of hormone refractory prostate cancer

#2024
20150190460
2015-07-09

OSTEOPONTIN PEPTIDE FRAGMENTS FOR USE IN SUPPRESSION OR PREVENTION OF TUMOR GROWTH

#2025
20150190459
2015-07-09

Method Of Reducing Injury To Mammalian Cells

#2026
20150183829
2015-07-02

RFamide-related peptides and methods thereof

#2027
20150182583
2015-07-02

METHODS FOR TREATMENT AND PREVENTION OF TAUOPATHIES BY INHIBITING ENDOTHELIN RECEPTORS

#2028
20150175659
2015-06-25

Peptide derivatives as antibiotics

#2029
20150175592
2015-06-25

Viral polymerase inhibitors

#2030
20150174197
2015-06-25

Peptoids useful for the mineralization of apatite

#2031
20150174196
2015-06-25

Peptide-based collagen modulators for wound healing and tissue repair

#2032
20150174195
2015-06-25

METHODS FOR INCREASING AND MOBILIZING HEMATOPOIETIC STEM CELLS

#2033
20150174192
2015-06-25

Pea protein peptides with anti activity

#2034
20150166626
2015-06-18

Ameliorating agent for blood-brain barrier dysfunction

#2035
20150166605
2015-06-18

Linear peptide antibiotics

#2036
20150166604
2015-06-18

Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof

#2037
20150166603
2015-06-18

Decoy peptides inhibiting protein phosphatase 1-mediated dephosphorylation of phospholamban

#2038
20150164978
2015-06-18

FORMULATIONS FOR A TIGHT JUNCTION EFFECTOR

#2039
20150158931
2015-06-11

CYSTEINE PROTEASE CAPTURING AGENTS

#2040
20150158912
2015-06-11

Treatment of IL-17 mediated disease by blocking SEFIR-SEFIR interactions

#2041
20150157766
2015-06-11

Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition

#2042
20150157719
2015-06-11

Aqueous Gelling Compositions of Soluble Active Pharmaceutical Peptides Providing Modified Release

#2043
20150152090
2015-06-04

COMPOSITIONS AND METHODS FOR TREATMENT

#2044
20150150980
2015-06-04

Methods and compositions for treating pain

#2045
20150148304
2015-05-28

Novel Peptides and Analogs for Use in the Treatment of Macrophage Activation Syndrome

#2046
20150148302
2015-05-28

Peptide inhibitors of caspase 2 activation

#2047
20150148295
2015-05-28

Controlled-Released Peptide Formulations

#2048
20150147320
2015-05-28

Ophthalmic drug delivery system containing phospholipid and cholesterol

#2049
20150141340
2015-05-21

METHOD OF TREATING AND PREVENTING OCULAR ANGIOGENESIS

#2050
20150141337
2015-05-21

Manufacture of degarelix

#2051
20150141324
2015-05-21

STABLE PEPTIDE-BASED FURIN INHIBITORS

#2052
20150141323
2015-05-21

Peptide-oligourea chimeric compounds and methods of their use

#2053
20150140125
2015-05-21

SYNERGISTIC CANCER THERAPY DRUG COMBINATIONS

#2054
20150140081
2015-05-21

COMPOSITIONS AND METHODS FOR TREATMENT

#2055
20150140080
2015-05-21

COMPOSITIONS AND METHODS FOR TREATMENT

#2056
20150140079
2015-05-21

COMPOSITIONS AND METHODS FOR TREATMENT

#2057
20150140078
2015-05-21

COMPOSITIONS AND METHODS FOR TREATMENT

#2058
20150140077
2015-05-21

COMPOSITIONS AND METHODS FOR TREATMENT

#2059
20150140075
2015-05-21

COMPOSITIONS AND METHODS FOR TREATMENT

#2060
20150140060
2015-05-21

Compositions and methods for promoting wound healing and tissue regeneration

#2061
20150140046
2015-05-21

Compounds which inhibit neuronal exocytosis

#2062
20150139907
2015-05-21

CALCIUM-BINDING AGENTS INDUCE HAIR GROWTH AND/OR NAIL GROWTH

#2063
20150133394
2015-05-14

Compositions and methods for increasing carnitine level in muscle tissue

#2064
20150132384
2015-05-14

Polymeric nanoparticles useful in theranostics

#2065
20150126460
2015-05-07

Co-administration of an agent linked to an internalization peptide with an anti-inflammatory

#2066
20150126456
2015-05-07

Method and pharmaceutical composition for use in the treatment of cancer

#2067
20150125549
2015-05-07

Peptides and use thereof in the treatment of large cell lung cancer

#2068
20150125522
2015-05-07

Oral delivery of peptide pharmaceutical compositions

#2069
20150125492
2015-05-07

Compositions for stimulation of mammalian innate immune resistance to pathogens

#2070
20150118315
2015-04-30

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

#2071
20150118288
2015-04-30

Lipid nanoparticle compositions and methods of making and methods of using the same

#2072
20150111837
2015-04-23

Method for producing a recombinant peptide and resultant peptide

#2073
20150111832
2015-04-23

Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs

#2074
20150110744
2015-04-23

Peptide agents for cancer therapy

#2075
20150110735
2015-04-23

High-speed centrifugal mixing devices and methods of use

#2076
20150105333
2015-04-16

LATENT HUMAN IMMUNODEFICIENCY VIRUS REACTIVATION

#2077
20150105332
2015-04-16

Somatostatin receptor agonist formulations

#2078
20150105330
2015-04-16

Active mixtures of acylated oligopeptides and troxerutin

#2079
20150104485
2015-04-16

Compounds for the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions

#2080
20150099697
2015-04-09

Method for reversing recent-onset type 1 diabetes (T1D) by administering substance P (sP)

#2081
20150094265
2015-04-02

Treatments for Gastrointestinal Disorders

#2082
20150094261
2015-04-02

Synthetic bile acid compositions and methods

#2083
20150094260
2015-04-02

BUFFERED OPHTHALMIC COMPOSITIONS AND METHODS OF USE THEREOF

#2084
20150093463
2015-04-02

Nutritional composition containing a peptide component with anti-inflammatory properties and uses thereof

#2085
20150093400
2015-04-02

Peptides for management of lactation

#2086
20150090267
2015-04-02

Compositions for treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances

#2087
20150087598
2015-03-26

TREATING MUC1-EXPRESSING CANCERS WITH HELICASE INHIBITORS

#2088
20150087595
2015-03-26

Methods and compositions for the prevention and treatment neuropathy

#2089
20150087583
2015-03-26

Dosing regimens for echinocandin class compounds

#2090
20150080314
2015-03-19

TOPICAL CORNEAL ANALGESIA USING NEUROTENSIN RECEPTOR AGONISTS AND SYNERGISTIC NEUROTENSIN COMBINATIONS WITHOUT DELAYING WOUND HEALING

#2091
20150080289
2015-03-19

Amphiphilic peptides comprising the formula I: (XYXY), and uses thereof

#2092
20150079179
2015-03-19

SUSTAINED RELEASE FORMULATIONS OF PEPTIDOMIMETIC DRUGS AND USES THEREOF

#2093
20150079154
2015-03-19

Medicament for treatment of liver cancer

#2094
20150079036
2015-03-19

Spiro[2.4]heptanes for treatment of Flaviviridae infections

#2095
20150071918
2015-03-12

PEPTIDES FOR THE TREATMENT OF CANCER

#2096
20150071871
2015-03-12

BIO-SYNTHETIC MATRIX AND USES THEREOF

#2097
20150065445
2015-03-05

Viral polymerase inhibitors

#2098
20150065424
2015-03-05

VIP fragments and methods of use

#2099
20150064284
2015-03-05

METHODS FOR PREVENTING OR TREATING INFECTIOUS DISEASES CAUSED BY EXTRACELLULAR MICROORGANISMS, INCLUDING ANTIMICROBIAL-RESISTANT STRAINS THEREOF, USING GALLIUM COMPOUNDS

#2100
20150064271
2015-03-05

strains for the production of bioactive peptides having anti-hypertensive and cholesterol-lowering effects